TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 12, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 3
- −2 vs. Q4 2022
- Portfolio value
- $139.9M
- −$95.3M (−40.5%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TNGXTango Therapeutics, Inc. | COM | 19,363,975 | $76.5M | 54.7% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,132,867 | $56.7M | 40.6% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 2,343,154 | $6.68M | 4.8% | 00.0% | Unchanged | History |
Sold out since Q4 2022 (2)
Positions held at the end of Q4 2022 that are gone from this filing.